Search Results for: RB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CREG1 cellular repressor of E1A stimulated genes 1
  • Neutrophil degranulation
CTBP1 C-terminal binding protein 1
  • Deactivation of the beta-catenin transactivating complex
  • SUMOylation of transcription cofactors
  • Repression of WNT target genes
  • Signaling by TCF7L2 mutants
  • Formic acid
CTSV cathepsin V
  • Endosomal/Vacuolar pathway
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Trafficking and processing of endosomal TLR
  • Assembly of collagen fibrils and other multimeric structures
  • MHC class II antigen presentation
  • RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
  • 3-amino-5-phenylpentane
  • 4-Methylpiperazin-1-Yl Carbonyl Group
CUX1 cut like homeobox 1
  • Signaling by cytosolic FGFR1 fusion mutants
  • Signaling by FGFR1 in disease
  • Intra-Golgi traffic
DGKZ diacylglycerol kinase zeta
  • Effects of PIP2 hydrolysis
  • alpha-Tocopherol succinate
DNMT1 DNA methyltransferase 1
  • PRC2 methylates histones and DNA
  • NoRC negatively regulates rRNA expression
  • SUMOylation of DNA methylation proteins
  • DNA methylation
  • Procaine
  • Azacitidine
  • Procainamide
  • Flucytosine
  • Decitabine
  • Palifosfamide
  • Epigallocatechin gallate
DVL1 dishevelled segment polarity protein 1
  • TCF dependent signaling in response to WNT
  • WNT mediated activation of DVL
  • PCP/CE pathway
  • PCP/CE pathway
  • Degradation of DVL
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Negative regulation of TCF-dependent signaling by DVL-interacting proteins
  • RHO GTPases Activate Formins
  • WNT5:FZD7-mediated leishmania damping
  • WNT5:FZD7-mediated leishmania damping
DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A
  • G0 and Early G1
  • N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
  • Fostamatinib
E2F1 E2F transcription factor 1
  • Activation of NOXA and translocation to mitochondria
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • CDC6 association with the ORC:origin complex
  • G2 Phase
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • Transcriptional Regulation by E2F6
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
E2F2 E2F transcription factor 2
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • CDC6 association with the ORC:origin complex
  • Cyclin D associated events in G1
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
E2F3 E2F transcription factor 3
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Oncogene Induced Senescence
  • CDC6 association with the ORC:origin complex
  • G2 Phase
  • Cyclin D associated events in G1
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
E2F4 E2F transcription factor 4
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • G0 and Early G1
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Cyclin E associated events during G1/S transition
  • G1/S-Specific Transcription
  • G1/S-Specific Transcription
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
E4F1 E4F transcription factor 1
EID1 EP300 interacting inhibitor of differentiation 1
ELF1 E74 like ETS transcription factor 1
  • RUNX1 regulates transcription of genes involved in BCR signaling
  • RUNX1 regulates transcription of genes involved in interleukin signaling
ENC1 ectodermal-neural cortex 1
EP300 E1A binding protein p300
  • Regulation of gene expression by Hypoxia-inducible Factor
  • RORA activates gene expression
  • Polo-like kinase mediated events
  • Pre-NOTCH Transcription and Translation
  • Pre-NOTCH Transcription and Translation
  • PPARA activates gene expression
  • PPARA activates gene expression
  • Formation of the beta-catenin:TCF transactivating complex
  • Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH1 Intracellular Domain Regulates Transcription
  • NOTCH2 intracellular domain regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • HATs acetylate histones
  • Attenuation phase
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • SUMOylation of transcription cofactors
  • Circadian Clock
  • B-WICH complex positively regulates rRNA expression
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • CD209 (DC-SIGN) signaling
  • Metalloprotease DUBs
  • Formation of TC-NER Pre-Incision Complex
  • Transcription-Coupled Nucleotide Excision Repair (TC-NER)
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • Activation of the TFAP2 (AP-2) family of transcription factors
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • RUNX3 regulates NOTCH signaling
  • RUNX3 regulates NOTCH signaling
  • Regulation of RUNX3 expression and activity
  • RUNX3 regulates p14-ARF
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH4 Intracellular Domain Regulates Transcription
  • Estrogen-dependent gene expression
  • NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
  • NGF-stimulated transcription
  • NGF-stimulated transcription
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • FOXO-mediated transcription of cell death genes
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Regulation of FOXO transcriptional activity by acetylation
  • Regulation of FOXO transcriptional activity by acetylation
  • Rubinstein-Taybi syndrome
FANCC FA complementation group C
  • Fanconi Anemia Pathway
  • TP53 Regulates Transcription of DNA Repair Genes
  • Fanconi anemia
FBP1 fructose-bisphosphatase 1
  • Gluconeogenesis
  • Adenosine phosphate
  • 2,5-Anhydroglucitol-1,6-Biphosphate
  • {4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol
  • Mdl-29951
  • Fructose-6-phosphate
  • MB-07803
  • Managlinat dialanetil
  • N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE
  • 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE
  • 2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE
  • 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE
  • Fructose-1,6-bisphosphatase deficiency
FBP2 fructose-bisphosphatase 2
  • Gluconeogenesis

Page 4 out of 10 pages